Pathways Project: Kidney Supportive Care
Public ClinicalTrials.gov record NCT04125537. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Pathways Project Collaborative Phase II: Implementation of Kidney Supportive Care in Practice
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The Pathways Collaborative is the first attempt to implement supportive (palliative) kidney care at multiple sites in the United States. While supportive kidney care is growing in other countries, notably Canada, Australia, and Great Britain, it is not yet known how to integrate it into the unique nephrology environment in the United States. In Phase 1 of Pathways (completed), we developed an evidence-based change packet of 14 best practices for integrating supportive care practices into the continuum of care for patients with end stage kidney disease (ESKD). In Phase 2 (described in this application), we will conduct a learning collaborative to help up to 15 dialysis and CKD centers implement these best practices. The learning collaborative is based on the IHI Collaborative Model for Achieving Breakthrough Improvement. This model is a tested systematic approach to quality improvement designed to help organizations close the gap between current and future practice based on evidence-based best practices. The Pathways Project faculty will work with up to 15 change teams at dialysis centers to create a system to identify seriously ill patients with kidney disease; conduct conversations with them so that their values, preferences, and goals for current and future medical treatment are known and respected; assess and address patients' physical, psychological and spiritual needs; and coordinate care throughout the healthcare system so patients receive only the care they want in settings in which they wish to be.
Study identification
- NCT ID
- NCT04125537
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 476 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2018
- Primary completion
- Aug 30, 2020
- Completion
- Oct 30, 2020
- Last update posted
- Sep 12, 2023
2018 – 2020
United States locations
- U.S. sites
- 13
- U.S. states
- 4
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kidney Center of Arvada | Arvada | Colorado | 80002 | — |
| Thornton Kidney Center | Thornton | Colorado | 80229 | — |
| Kidney Center of Westminster | Westminster | Colorado | 80031 | — |
| George Washington University | Washington D.C. | District of Columbia | 20052 | — |
| Washington DC VA Medical Center | Washington D.C. | District of Columbia | 20422 | — |
| Atlantic Dialysis Astoria | Astoria | New York | 11106 | — |
| Rogosin Institute Auburndale | Flushing | New York | 11358 | — |
| Atlantic Dialysis Newton | Long Island City | New York | 11102 | — |
| Rogosin Institute Manhattan East | New York | New York | 10021 | — |
| Atlantic Dialysis Ridgewood | Ridge | New York | 11385 | — |
| Rogosin Institute Woodside | Woodside | New York | 11377 | — |
| Dallas Nephrology Associates | Dallas | Texas | 75204 | — |
| Desoto Regional Dialysis Center | DeSoto | Texas | 75115 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04125537, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 12, 2023 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04125537 live on ClinicalTrials.gov.